Steven J Kussick
Overview
Explore the profile of Steven J Kussick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Love J, Thompson K, Kilgore M, Westerhoff M, Murphy C, Papanicolau-Sengos A, et al.
Am J Clin Pathol
. 2017 Aug;
148(3):236-242.
PMID: 28821198
Objectives: CD200 expression has been well studied in hematopoietic malignancies; however, CD200 expression has not been well-characterized in neuroendocrine neoplasms. We examined CD200 expression in 391 neuroendocrine neoplasms from various...
2.
Bohling S, Davis E, Thompson K, Kussick S, Love J
Cytometry B Clin Cytom
. 2015 Nov;
90(6):493-498.
PMID: 26584149
Background: CD200 is a membrane bound glycoprotein that is expressed by a variety of normal tissues and hematopoietic malignancies. Flow cytometric analysis of CD200 expression has utility in the evaluation...
3.
Keeney M, Halley J, Rhoads D, Ansari M, Kussick S, Karlon W, et al.
Arch Pathol Lab Med
. 2015 Feb;
139(10):1276-80.
PMID: 25695342
Context: Flow cytometry is often applied to minimal residual disease (MRD) testing in hematolymphoid neoplasia. Because flow-based MRD tests are developed in the laboratory, testing methodologies and lower levels of...
4.
Mannelli L, Monti S, Love J, Kussick S, McLuen A, Behnia F
Clin Nucl Med
. 2014 Oct;
40(3):247-9.
PMID: 25290290
A 49-year-old woman with history of breast cancer presented with pain at the level of the left anterior proximal tibia. An x-ray of the tibia demonstrated a lytic cortical lesion...
5.
Tse C, Hwang H, Goldstein L, Kandalaft P, Wiley J, Kussick S, et al.
J Clin Oncol
. 2011 Sep;
29(31):4168-74.
PMID: 21947821
Purpose: The ratio of human epidermal growth factor receptor 2 (HER2) to CEP17 by fluorescent in situ hybridization (FISH) with the centromeric probe CEP17 is used to determine HER2 gene...
6.
Gown A, Goldstein L, Barry T, Kussick S, Kandalaft P, Kim P, et al.
Mod Pathol
. 2008 May;
21(10):1271-7.
PMID: 18487992
The American Society of Clinical Oncologists and College of American Pathologists have recently released new guidelines for laboratory testing of HER2 status in breast cancer, which require high levels (95%)...
7.
Wood B, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick S, et al.
Cytometry B Clin Cytom
. 2007 Sep;
72 Suppl 1:S14-22.
PMID: 17803189
Immunophenotyping by flow cytometry has become standard practice in the evaluation and monitoring of patients with hematopoietic neoplasia. However, despite its widespread use, considerable variability continues to exist in the...
8.
Fromm J, Kussick S, Wood B
Am J Clin Pathol
. 2006 Oct;
126(5):764-80.
PMID: 17050074
We demonstrate the feasibility of using flow cytometry (FC) to identify the Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (CHL). Initial flow cytometric studies of the HRS cell...
9.
Yaziji H, Battifora H, Barry T, Hwang H, Bacchi C, McIntosh M, et al.
Mod Pathol
. 2006 Mar;
19(4):514-23.
PMID: 16554731
We evaluated the sensitivity and specificity of 10 monoclonal and two polyclonal antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma (AdCA) using immunohistochemistry (IHC). The antibodies were directed against the mesothelial-associated...
10.
Kussick S, Fromm J, Rossini A, Li Y, Chang A, Norwood T, et al.
Am J Clin Pathol
. 2005 Jul;
124(2):170-81.
PMID: 16040286
The ability of 4-color flow cytometry (FC) to help identify myelodysplastic syndromes (MDSs) was evaluated in 124 bone marrow aspirates from unselected patients with unexplained cytopenias and/or monocytosis. The morphologic...